| Bioactivity | Mal-PEG4-Val-Cit-PAB-MMAE is part of a drug-linker conjugate for ADC. Mal-PEG4-Val-Cit-PAB-MMAE contains a degradable ADC linker Mal-PEG4-Val-Cit-PAB (HY-126672) and a potent tubulin inhibitor MMAE (HY-15162)[1]. |
| Formula | C73H115N11O19 |
| Molar Mass | 1450.76 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *该产品在溶液状态不稳定，建议您现用现配，即刻使用。 |
| Reference | [1]. Beck A, et al. Strategies and challenges for the next generation of antibody–drug conjugates[J]. Nature reviews Drug discovery, 2017, 16(5): 315-337. |
Mal-PEG4-Val-Cit-PAB-MMAE
CAS: F: C73H115N11O19 W: 1450.76
Mal-PEG4-Val-Cit-PAB-MMAE is part of a drug-linker conjugate for ADC. Mal-PEG4-Val-Cit-PAB-MMAE contains a degradable AD
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.